SLC7A5 and cancer: The model was reinforced by the concurrent discovery that CD147 and CD98hc nucleated a “metabolic activation-related complex” with LAT1, ASCT2, and monocarboxylate transporters (MCT) in the plasma membrane of cancer cells [13].